|
|
Article: FluGen Cell-Based, Egg-Free Method Produces Novel 2009 H1N1 Vaccine Virus.
- Article from:
- Vaccine Weekly
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines, announced that its proprietary CHO-cell-based production system has generated novel 2009 H1N1 influenza vaccine virus without the use of eggs during any step of production (see also FluGen Inc.).
Unlike traditional vaccine production methods, FluGen's CHO-based system does not use eggs. The company expects its cell-based, egg-free method to readily transfer to full-scale vaccine production and is in the process of developing a highly-efficient, production-scale system that will be available in the near future.
FluGen's system would avoid the costly and ...